![Nils Aage Brünner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nils Aage Brünner
Directeur Général chez
Timpco ApS
Profil
Nils Aage Brünner was the founder of Oncology Venture Sweden AB, founded in 2012, where he held the title of Chief Scientific Officer.
He was also the founder of Scandion Oncology A, founded in 2017, where he held the title of Chief Scientific Officer from 2020 to 2021.
Dr. Brünner's current job(s) include being the Chief Executive Officer at Timpco ApS, Director at 2cureX ApS since 2020, Director at Danish National Research Foundation, Director at CytoTrack ApS, Director at Sino Danish Breast Cancer Research Centre, Director at Genetelligence, Professor at the University of Copenhagen since 2002, and Head-Translational Cancer Research Unit at Danish Cancer Society since 2013.
Dr. Brünner's former job(s) include being the Chief Executive Officer at Timpco HJN ApS, Director at LiPlasome Pharma A, Director at European Organisation for Research & Treatment of Cancer from 2003 to 2006, Independent Director at 2cureX AB, Independent Director at Scandion Oncology A, Director at Gibson Oncology LLC, Assistant Professor at National Cancer Institute, and Chief Executive & Marketing Officer at Wntresearch AB. Dr. Brünner obtained a doctorate degree from the University of Copenhagen in 1988.
Postes actifs de Nils Aage Brünner
| Sociétés | Poste | Début |
|---|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 15/09/2009 |
Sino Danish Breast Cancer Research Centre | Directeur/Membre du Conseil | - |
Danish National Research Foundation | Corporate Officer/Principal | - |
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services Operates as disease-fighting association | Corporate Officer/Principal | 01/01/2013 |
Timpco ApS | Directeur Général | - |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Directeur/Membre du Conseil | 01/01/2020 |
CytoTrack ApS
 CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology Provides medical scanners for rare cell detection systems | Directeur/Membre du Conseil | - |
Genetelligence | Directeur/Membre du Conseil | - |
Anciens postes connus de Nils Aage Brünner
| Sociétés | Poste | Fin |
|---|---|---|
| SCANDION ONCOLOGY A/S | Directeur Général | 01/10/2020 |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Nils Aage Brünner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
LiPlasome Pharma A/S
 LiPlasome Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, produces and supplies drugs for chemotherapy treatment | Health Technology |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
Danish National Research Foundation | |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
CytoTrack ApS
CytoTrack ApS Electronic Equipment/InstrumentsElectronic Technology Provides medical scanners for rare cell detection systems | Electronic Technology |
Timpco ApS | |
European Organisation for Research & Treatment of Cancer
 European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization | Commercial Services |
Danish Cancer Society
Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services Operates as disease-fighting association | Commercial Services |
Sino Danish Breast Cancer Research Centre | |
Oncology Venture Sweden AB
 Oncology Venture Sweden AB BiotechnologyHealth Technology Provides oncology products | Health Technology |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Timpco HJN ApS | |
Gibson Oncology LLC
 Gibson Oncology LLC BiotechnologyHealth Technology Engages in drug discovery and development for glioblastoma & other brain tumors | Health Technology |
Genetelligence |
